Mission Statement, Vision, & Core Values (2026) of Tofflon Science and Technology Group Co., Ltd.

Founded in 1993 and listed as 300171.SZ, Tofflon Science and Technology Group Co., Ltd., headquartered in Shanghai, has grown into a global pharmaceutical-equipment and services provider organized into four core divisions-Bio-process, Preparation Equipment, Engineering, and Food & Beverage-serving injectables, solid preparations, chemical APIs, bioengineering, traditional Chinese medicine and food applications; with a network of 26 domestic subsidiaries and 13 overseas subsidiaries and manufacturing/R&D bases in China, the USA and Germany, Tofflon pursues a mission to deliver advanced pharmaceutical processes, equipment, systems and EPC solutions that advance human health, a vision to build a next-generation intelligent pharmaceutical manufacturing platform and expand "from China Tofflon to Global Tofflon," and core values of integrity, dedication, study and innovation that drive talent development, sustainable training systems and ongoing projects across Southeast Asia and Europe.

Tofflon Science and Technology Group Co., Ltd. (300171.SZ) - Intro

• Innovation: continuous investment in R&D to lead in process optimization, aseptic technologies, and digitalization.
• Quality & Compliance: adherence to GMP, ISO standards, and international regulatory requirements.
• Customer Centricity: customized solutions and lifecycle services to maximize client productivity.
• Sustainability: reducing environmental impact across manufacturing and engineering operations.
• Integrity & Collaboration: transparent partnerships across global supply chains and research networks.

• Bio-process Division - single-use and stainless-steel bioreactors, downstream processing, and integrated bioprocess lines for biologics and vaccines.
• Preparation Equipment Division - equipment for aseptic injectables, lyophilization, filling and sealing, tableting, coating, and capsule solutions for oral solid dosage forms.
• Engineering Division - turnkey project delivery, plant design, EPC services, validation, and automation systems integration.
• Food & Beverage Division - process equipment and packaging solutions adapted from pharmaceutical-grade engineering for high-hygiene food production.

• GMP-aligned equipment designs for sterile manufacturing and aseptic filling lines.
• Compliance with international standards (ISO, CE) and support for clients' regulatory submissions (FDA, EMA, NMPA).
• Lifecycle service offerings including qualification, validation, maintenance, and digital remote support to minimize downtime and ensure audit readiness.

• Scaling biologics and aseptic manufacturing product lines to capture growth in vaccines and monoclonal antibodies.
• Increasing single-use systems and continuous manufacturing solutions to meet customer demand for flexible capacity.
• Investing in digitalization and automation for Industry 4.0-ready plants and remote service capabilities.

Tofflon Science and Technology Group Co., Ltd. (300171.SZ) - Overview

• Mission: Provide advanced, applicable pharmaceutical processes, equipment, systems and EPC solutions to global pharmaceutical companies, contributing to human health.
• Strategic focus: Develop and apply equipment technology with deep expertise in biopharmaceutical manufacturing (single‑use systems, aseptic filling, lyophilization, isolators, formulation and process automation).
• Transformation goal: Evolve from 'China Tofflon' to 'Global Tofflon' - from an equipment supplier to an integrated solution provider for pharmaceutical manufacturing systems and engineering.
• Commitment: Enhance efficiency, reliability and regulatory compliance of drug production through technological innovation, platformization and lifecycle services.

• R&D intensity and technology pipeline: sustained high R&D spending to accelerate proprietary equipment and process solutions for small‑molecule, sterile and biologics production.
• Platform buildout: modular, compliant lines (e.g., aseptic filling, vial/ampoule processing, isolator and lyophilizer suites) configured for local and multinational pharma customers.
• Service and EPC expansion: integrated project delivery from process design through qualification, plus lifecycle service contracts to ensure long‑term process reliability.

• Product strategy: Prioritize modular, GMP‑compliant platforms enabling rapid technology transfer and scale‑up for contract manufacturers and innovators.
• Customer mix: Serve CROs/CDMOs, domestic and multinational pharma, vaccine and cell/gene therapy developers with end‑to‑end solutions.
• Financial strategy: Reinvest margins into R&D and capacity expansion to support migration from component sales to high‑margin EPC and turn‑key platform projects.

• Advanced equipment engineering - aseptic filling lines, lyophilizers, blenders, isolators and single‑use handling systems.
• Process sciences - formulation, aseptic processing, lyophilization cycles and scale‑up methodologies focused on yield and stability.
• Systems integration & digitalization - MES, batch control and data integrity solutions to meet global regulatory expectations (FDA, EMA, NMPA).
• EPC and lifecycle services - turnkey facility delivery, validation/qualification and long‑term maintenance contracts.

Tofflon Science and Technology Group Co., Ltd. (300171.SZ) - Mission Statement

• Deliver integrated pharmaceutical manufacturing systems that combine equipment design, process engineering and digitalized control to shorten time‑to‑market and increase manufacturing yield.
• Advance drug machine science through sustained R&D investment, scaling modular solutions from lab to commercial lines.
• Provide turnkey engineering, installation, validation and lifecycle services for pharma and biotech clients globally.

• Technology‑led intelligent manufacturing: drive digital integration (MES, automation, PAT) across equipment and processes to enable continuous and hybrid manufacturing models.
• Customer‑centric platform: deliver solutions for R&D, pilot and commercial stages with modular, repeatable units and defined transfer‑of‑technology pathways.
• Global expansion: accelerate overseas footprint with active projects in Southeast Asia and Europe and partnerships for local deployment and service networks.

• Integrated engineering: couple equipment R&D with process science teams to offer validated transfer packages that reduce scale‑up risk.
• All‑natural materials focus: develop and qualify performance materials that meet regulatory and sustainability targets for GMP environments.
• Intelligent manufacturing roadmap: embed digital twins, PAT sensors and cloud‑based monitoring to enable predictive maintenance and quality‑by‑design control.
• Global service network: localize installation, validation and after‑sales with service centers and trained partners in target markets.

• Time‑to‑commercialization: target 20-40% reduction in scale‑up cycle for customers using Tofflon platforms versus traditional bespoke builds.
• Yield improvements: process engineering and equipment coherence targeting single‑digit to low‑double‑digit percentage increases in API and formulation yields.
• Customer TCO (total cost of ownership): design and lifecycle services aimed at lowering operating costs through automation and standardized spare‑parts kits.

Tofflon Science and Technology Group Co., Ltd. (300171.SZ) Vision Statement

• Integrity: rigorous quality systems, traceability in production and strict regulatory compliance across GMP and international standards.
• Dedication: performance targets tied to accountability and continuous improvement cycles in manufacturing and service delivery.
• Study: systematic professional learning, knowledge sharing and leaning into evidence-based process optimization.
• Innovation: sustained investment in new product design, automation, and smart manufacturing solutions.

• Role-based talent allocation to match business priorities (R&D, manufacturing, quality assurance, sales).
• Performance-linked promotion paths and meritocratic succession planning.
• Compensation packages blending competitive pay, equity-like incentives and career development opportunities.

• Core technical training: regulatory compliance, equipment engineering, validation techniques.
• Management & leadership development: project management, cross-functional collaboration and strategic thinking.
• Continuous learning infrastructure: e-learning platforms, in-house academies and external partnerships with universities and research institutes.

• Quality and Compliance: lower defect rates and faster regulatory approvals through well-trained QA teams.
• Innovation Pipeline: R&D outputs (new models and patents) accelerated by targeted talent programs and funding.
• Employee Retention: structured career paths and development reduce turnover in core technical roles.

• Technical Apprenticeship: entry-to-mid-level career funnels with certification completion targets.
• Leadership Track: annual cohorts for potential managers, including rotation through manufacturing, R&D and commercial teams.
• External Partnerships: joint training and research projects with universities to seed advanced skills and recruitment pipelines.